A plain-language guide

cystic fibrosis

What is known, what is still uncertain, and what is actively debated, written plainly, and built only from published medical research.

Early map · 8 sourced statements Every statement names its source Updated 2026-06-12
Please read this first. This guide is a companion to your medical team, not a replacement, and it is not medical advice. Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet, not that it is unknown to medicine. cystic fibrosis is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind. For anything about your own situation, your clinicians hold the full picture. How this guide is built and why.

What it is

Cystic fibrosis is an inherited condition caused by changes in the CFTR gene. CFTR normally moves salt and water across cell surfaces; when it fails, secretions become thick and sticky, mainly damaging the lungs and the pancreas.

Signs and symptoms

Elevated sweat chloride

A high level of chloride in sweat is the hallmark diagnostic finding in cystic fibrosis (values around 100 mmol/L are well above the normal range).

Limited evidenceSource: OMIM:219700
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42243036
Notesplain_language confirmed from PMID:42243036 via curation 2026-06-12.
Last reviewed2026-06-12

Recurrent bronchopulmonary infections

Thick airway mucus leads to repeated and chronic lung infections, often with bacteria such as Pseudomonas that are hard to clear, driving progressive lung damage.

Limited evidenceSource: OMIM:219700
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42174504
Notesplain_language confirmed from PMID:42174504 via curation 2026-06-12.
Last reviewed2026-06-12

Autosomal recessive inheritance

Cystic fibrosis is inherited in an autosomal recessive pattern, occurring when a child inherits a changed copy of CFTR from both parents.

Limited evidenceSource: OMIM:219700
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41898631
Notesplain_language confirmed from PMID:41898631 via curation 2026-06-12.
Last reviewed2026-06-12

Exocrine pancreatic insufficiency

The pancreas often cannot deliver its digestive enzymes (exocrine pancreatic insufficiency), so fat is poorly absorbed and stools become greasy, affecting growth and nutrition.

Limited evidenceSource: OMIM:219700
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42242564
Notesplain_language confirmed from PMID:42242564 via curation 2026-06-12.
Last reviewed2026-06-12

Meconium ileus

Meconium ileus, a blockage of the newborn bowel by thick meconium, can be the first sign of cystic fibrosis at birth.

Limited evidenceSource: OMIM:219700
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42242564
Notesplain_language confirmed from PMID:42242564 via curation 2026-06-12.
Last reviewed2026-06-12

Treatment and management

What the research describes, not a recommendation. Treatment decisions belong with your clinician.

This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.

CFTR modulators

CFTR modulators (such as elexacaftor/tezacaftor/ivacaftor) act on the faulty CFTR protein itself and have become the cornerstone of cystic fibrosis management for eligible genotypes.

Used to help with: Cystic fibrosis.

Limited evidenceSource: PMID:41809454
The source text this rests on
“As CFTR modulators become the cornerstone of CF management, vigilance for hepatotoxicity is critical.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:41809454 via curation 2026-06-12
Last reviewed2026-06-12

Turn this into questions for your doctor

The hardest part is often knowing what to ask. PatientLead Health helps families turn what is on this page into the right questions for their care team.

Prepare for your appointment with PatientLead Health →

How to read the evidence labels

Widely acceptedSpecialists broadly agree on this.
Strong evidenceBacked by solid, repeated research.
Moderate evidenceReasonable evidence, still being confirmed.
Limited evidenceSome evidence, but not yet convincing.
Early evidenceAn early finding that needs more study.
Experts disagreeResearchers actively disagree about this.

Where this comes from

This guide is built from 2 published source(s). Every claim above links back to one of them. Click any source ID to read the original on PubMed.

OMIM:219700 · Orphanet/HPO annotations for Cystic fibrosis
PMID:41809454 · Decoding liver injury in cystic fibrosis: How to tell drug-induced liver injury from cystic fibrosis liver disease.